When Do ML/AI Models Outperform Scorecards in Microfinance? A PRISMA-Based Systematic Literature Review
European Journal of Management Issues · 2026-05-25 · 34 (2) · 63-72
DOI: 10.15421/192606 ↗At a glance
Systematische Übersicht in European Journal of Management Issues, published online on 2026-05-25. Written by Jorge Alberto Martínez Escandón. 43 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Purpose
To determine under which data, validation, and governance conditions machine learning models outperform traditional scorecards in microfinance, and to examine how explainability and fairness can be integrated without materially compromising predictive performance. Design/Method/Approach: A PRISMA-based systematic literature review of studies comparing ML/AI models with logistic scorecards in microfinance (2005–2025). The review standardizes comparative effects using ΔAUC and ΔKS, distinguishes cross-validation from out-of-time validation, and synthesizes evidence on calibration, explainability, fairness, and model governance.
Findings
ML/AI models outperform traditional scorecards primarily when datasets contain nonlinear, behavioral, temporal, or relational information and when evaluation relies on out-of-time validation. Calibration and SHAP-based explainability can be incorporated with limited impact on predictive performance, while fairness adjustments generally involve only minor trade-offs. Theoretical Implications: The review demonstrates that the superiority of ML/AI models is theoretically justified only when accompanied by robust governance mechanisms, including calibration, explanation stability, fairness assessment, and deployment-oriented validation. It also proposes an integrated conceptual framework linking predictive performance with responsible AI governance in microfinance. Practical Implications: The findings provide a practical framework for selecting, validating, and governing credit-risk models in microfinance institutions. The proposed deployment checklist supports practitioners in choosing appropriate modelling approaches according to data characteristics, implementing explainability and fairness mechanisms, and strengthening model governance through calibration, out-of-time validation, and continuous monitoring. Originality/Value: This review synthesizes empirical evidence through a governance-oriented perspective by integrating predictive performance, explainability, fairness, and regulatory requirements into a unified analytical framework. Unlike previous reviews, it identifies the specific conditions under which ML/AI models provide defensible advantages over traditional scorecards and proposes a structured checklist for responsible implementation in microfinance. Research Limitations/Future Research: The review is limited by the relatively small number of eligible studies, the exclusive use of the Scopus database, and the heterogeneity of datasets, validation strategies, and reported metrics. Future research should expand evidence through multi-database systematic reviews, standardized reporting protocols, open benchmark datasets with temporal validation, and comparative evaluations of fairness, calibration, and explainability across diverse microfinance settings. Paper Type: Conceptual JEL Classification: C45, C52, G21, O16, C55
Cite
APA
Escandón, J. A. M. (2026). When Do ML/AI Models Outperform Scorecards in Microfinance? A PRISMA-Based Systematic Literature Review. European Journal of Management Issues, 34(2), 63-72. https://doi.org/10.15421/192606
Vancouver
Escandón JAM. When Do ML/AI Models Outperform Scorecards in Microfinance? A PRISMA-Based Systematic Literature Review. European Journal of Management Issues. 2026;34(2):63-72. doi:10.15421/192606
BibTeX
@article{Escandn2026,
author = {Escandón, Jorge Alberto Martínez},
title = {When Do ML/AI Models Outperform Scorecards in Microfinance? A PRISMA-Based Systematic Literature Review},
journal = {European Journal of Management Issues},
year = {2026},
volume = {34},
number = {2},
pages = {63--72},
doi = {10.15421/192606}
}
EUVIMED